Your session is about to expire
← Back to Search
Self-Management Program for Blood Cancer Survivors Post-Stem Cell Transplant (INSPIRE Trial)
INSPIRE Trial Summary
This trial is testing a self-management program to help cancer survivors after stem cell transplant. The goal is to reduce stress and improve health care.
INSPIRE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowINSPIRE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.INSPIRE Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have had another type of cancer that spread to other parts of your body within the past two years, except for non-melanoma skin cancer.You have survived for 2-5 years after your last hematopoietic stem cell transplant (HCT).
- Group 1: Group I (INSPIRE, survivorship care plan)
- Group 2: Group II (usual care)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could you please tell us more about the potential risks of Survey Administration?
"There is some data to support the efficacy of Survey Administration and it has undergone multiple rounds of testing, so we feel confident in its safety rating it a 3."
Are there any limitations on how many people can be enrolled in this research?
"In order to run this trial, 980 eligible patients are required. These individuals can be recruited from Loyola University Medical Center and Moffitt Cancer Center, which are located in Maywood, Illinois and Tampa, Florida respectively."
Can new patients enroll in this clinical research project?
"The latest information from clinicaltrials.gov suggests that this trial is still open to new patients. The listing was first posted on November 5th 2020, with the 6/3/2022 update being the most recent available."
Share this study with friends
Copy Link
Messenger